MBCL-21. EARLY CHILDHOOD MEDULLOBLASTOMA: SUBGROUP-SPECIFIC SURVIVAL IN PATIENTS TREATED WITH SYSTEMIC CHEMOTHERAPY AND INTRAVENTRICULAR MTX TO AVOID CRANIOSPINAL RADIOTHERAPY

PURPOSE/METHODS: Methylation-based tumor classification results were obtained from 86 patients younger than four years with medulloblastoma treated with systemic chemotherapy and intraventricular methotrexate to avoid craniospinal radiotherapy (CSI). 70 were HIT trial participants and 16 observation...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Neuro Oncol
Päätekijät: Mynarek, Martin, Kool, Marcel, Schueller, Ulrich, von Hoff, Katja, Sharma, Tanvi, Rudneva, Vasilisa, Pietsch, Torsten, Northcott, Paul, Juhnke, B -Ole, Meissner, Barbara, Warmuth-Metz, Monica, Kortmann, Rolf D, Robinson, Giles, von Deimling, Andreas, Pfister, Stefan, Rutkowski, Stefan
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2018
Aiheet:
Abstracts
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6012787/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy059.417
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia